enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. New schizophrenia drug gets FDA approval, taking novel ... - AOL

   www.aol.com/news/schizophrenia-drug-gets-fda...

   September 27, 2024 at 2:25 PM. New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder. A new drug has been approved for the treatment of schizophrenia in adults ...

3. This FDA-approved drug promises a new way to treat schizophrenia

   www.aol.com/fda-approved-drug-promises-way...

   Updated September 29, 2024 at 12:48 PM. People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday ...

4. Bristol Myers wins US FDA approval for new type of ...

   www.aol.com/news/us-fda-approves-bristol-myers...

   September 27, 2024 at 6:06 AM. By Bhanvi Satija and Michael Erman. (Reuters) -The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it ...

5. Ulotaront - Wikipedia

   en.wikipedia.org/wiki/Ulotaront

   Ulotaront (INN; [1] developmental codes SEP-363856, SEP-856) is an investigational antipsychotic that is undergoing clinical trials for the treatment of schizophrenia and Parkinson's disease psychosis. [2][3] The medication was discovered in collaboration between PsychoGenics Inc. and Sunovion Pharmaceuticals [2] (which was subsequently merged ...

6. Lumateperone - Wikipedia

   en.wikipedia.org/wiki/Lumateperone

   Lumateperone. Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the butyrophenone class. It is approved for the treatment of schizophrenia as well as bipolar depression, as either monotherapy or adjunctive therapy (with lithium or valproate). [ 2 ] It is developed by Intra-Cellular Therapies, licensed ...

7. Olanzapine/samidorphan - Wikipedia

   en.wikipedia.org/wiki/Olanzapine/samidorphan

   Olanzapine/samidorphan, sold under the brand name Lybalvi, is a fixed-dose combination medication for the treatment of schizophrenia and bipolar I disorder. [1] It contains olanzapine, an atypical antipsychotic, and samidorphan, an opioid antagonist.